Abstract
The plant polyphenol trans-resveratrol (3, 5, 4′-trihydroxystilbene) mainly found in grape, peanut and other few plants, displays a wide range of biological effects. Numerous in vitro studies have described various biological effects of resveratrol. In order to provide more information regarding absorption, metabolism, and bioavailability of resveratrol, various research approaches have been performed, including in vitro, ex vivo, and in vivo models. In recent years, the induction of resveratrol synthesis in plants which normally do not accumulate such polyphenol, has been successfully achieved by molecular engineering. In this context, the ectopic production of resveratrol has been reported to have positive effects both on plant resistance to biotic stress and the enhancement of the nutritional value of several widely consumed fruits and vegetables. The metabolic engineering of plants offers the opportunity to change the content of specific phytonutrients in plant - derived foods. This review focuses on the latest findings regarding on resveratrol bioproduction and its effects on the prevention of the major pathological conditions in man.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Recently, the interest in antioxidants without vitamin activity, such as stilbenes, has been increasing. As far as concerns stilbenes, resveratrol has been suggested to play an important role in the prevention of a number of pathological conditions in man, such as cardiovascular diseases, neurodegenerative disorders [1] and carcinogenesis [2]. Resveratrol also inhibits platelet aggregation and exhibits antioestrogenic activity [3–5]. Epidemiological studies confirmed the positive effects of a diet rich in this type of antioxidant in overcoming some degenerative disorders caused by early ageing of the cells [6–8]. However, resveratrol together with many of the best-characterized health-promoting phytochemicals are absent or present only at low levels in edible plants or plant-derived products. Therefore, an improvement in these levels by means of manipulation of secondary plant metabolism is currently being attempted to ensure adequate dietary intake of these nutrients and increase their consumption [9–12].
Chemical Properties and Biosynthesis of Resveratrol in Plants
Resveratrol and its 3-O-β-D-glucoside derivative share a chemical structure similar to that of other polyphenol-type stilbens (Fig. 1). In plant tissues, its production is either constitutive or inducible and is controlled by the key enzyme, stilbene synthase (STS), which belongs to a multigene family of the type III group of the polyketide synthase superfamily [13, 14]. STS catalyses the condensation of three molecules of coumaroyl-CoA to form resveratrol. The synthesis of resveratrol takes place in a single enzymatic step with CoA-esters of cinnamic acid derivatives and three malonyl-CoA units as starting blocks. STS and chalcone synthase (CHS) are key enzymes of the flavonoid biosynthesis pathway (Fig. 2). These enzymes, competing for the same substrates, share a high degree of homology and both contain an essential cysteine residue, namely Cys 164, considered as their active site.
The synthesis of resveratrol is strongly enhanced by fungal attacks, UV irradiation and other environmental stress conditions [13–15]. Resveratrol levels peak approximately 24 h after stress exposure, and decrease after 42–72 h as a result of activation of stilbene oxidase [16, 17].
Resveratrol exists in two stereoisoforms with configuration cis- or trans-, the latter being the most widely studied, although cis-resveratrol may also possess health promoting properties. In nature, the most abundant form of resveratrol would appear to be the 5,3,4′-dihydroxystilbene-3-O-β-D-glucopyranoside. The number as well as the position of moieties play an important role in the biological activity of the compound [6–18].
Edible Plants Sources of Resveratrol
Stilbenes are small naturally occurring phenolic compounds found in a wide range of plant – derived food; among which, berries, such as deerberry, cowberry, blueberry, and lingonberry, are important sources [19, 20]. Resveratrol is biosynthetically correlated to stilbenes, but its biosynthesis is restricted to only a few plant species commonly used for human consumption among which are pine, peanuts, grapes, bilberry, and mulberry [13–17, 21, 22].
The most abundant levels of naturally occurring resveratrol are found in the roots of Japanese Knotweed (Poligonum cuspidatum), which has been used in traditional Asian herb medicine for hundreds of years in the treatment of inflammation [15]. Grape is probably the most important source of resveratrol, since the compound is also found in wine. In addition to its considerable economic value, grapevine (Vitis vinifera) and wine are now considered a key source of health-promoting secondary metabolites, especially antioxidant polyphenols such as resveratrol [23]. In red wine, it is found in relatively low quantities (0.3–7 mg/l aglycon form of resveratrol, and approximately 15 mg/l glycoside form) [24, 25].
The economic importance of grapevine has encouraged many researchers to study the physiological and molecular basis of berry development, particularly those processes affecting wine quality [26]. The availability of high-throughput analysis methods and high-quality information regarding the grapevine genome has led to the novel findings concerning the physiology of berry development at the transcriptome, proteome, and metabolome levels [27, 28].
In this species, a large array of STS genes, with 43 genes, identified and 20 of which shown to be expressed, thus suggesting the importance of stilbene metabolism for grapevine [29].
Resveratrol and Health Benefits: Effects In Vivo and In Vitro
Resveratrol possesses numerous important bioactivities including anti-inflammatory, antioxidant and antiaggregatory functions, and modulation of lipoprotein metabolism [30]. It has also been shown to possess chemopreventive properties against certain forms of cancer and cardiovascular disorders and to have positive effects on longevity [31–37]. Moreover, trans-resveratrol appears to protect against diabetes [38] and neurodegenerative disorders [39], due to induction of Sirtuin-1 genes [40]. Trans-resveratrol might also contribute to increasing the lifespan of metazoans and mice by miming the effect of caloric restriction and thus decreasing age-related signs [41, 42]. Experimental studies have shown that resveratrol exhibits both anti-inflammatory and cardioprotective potential by inhibiting the expression of inflammatory mediators and the monocyte adhesion to vascular endothelial cells [34, 35]. Considering the broad spectrum of protective properties, it has been proposed that resveratrol in red wine may explain the so-called “French Paradox” [43–46].
Resveratrol Bioavailability
Proof of the in vivo efficacy of resveratrol in man has been even less convincing. One of the main reasons for the in vitro/in vivo discrepancies may be the lack of information on resveratrol bioavailability in vivo, in particular following oral administration. Concentrations of resveratrol detected in tissue or at the cellular sites of action do not appear to be sufficiently adequate to demonstrate efficacy in man [47, 48].
The wide range of concentrations and doses used to achieve the various effects reported for resveratrol, both in in vitro cell culture and in animal studies, give raise to various questions regarding the concentrations that can be achieved in vivo. Furthermore, resveratrol has a short initial half-life and is considerably metabolized in the body. Nevertheless, the beneficial effects of resveratrol have been observed for thousands of years in the form of “materia medica”, such as grapes and Ko-jo-kon, confirming the concept of the long-term effects of low levels of pharmacologically active substances. In this regard, it is important to better understand the molecular mechanisms of the long-term effects of resveratrol as far as concerns communication between functionally different cells.
Regarding the interaction of resveratrol with cell membranes, few studies have been published so far. It is believed, however, that this interaction may be involved in the biological activities of resveratrol since trans-membrane proteins are one of its cellular targets. Indeed, resveratrol is able to modulate the membrane organization which may consequently affect protein function. Therefore, the intracellular effects of resveratrol and the effects of this compound at membrane level were also revised since these aspects are essential for a better understanding of the pharmacological and therapeutic activities of this bioactive compound. Animal studies have been frequently used to investigate the bioavailability of phenolic compounds. In order to obtain information on absorption, metabolism, and the consequent bioavailability of resveratrol, various research approaches have been performed, including in vitro, ex vivo, and in vivo models. Most studies indicate that oral bioavailability of resveratrol is very low due to poor absorption and rapid and extensive metabolism and the consequent formation of various metabolites i.e., resveratrol glucuronides and resveratrol sulfates [49].
Resveratrol Delivery
Despite the favorable therapeutic effects of resveratrol, the pharmacokinetic properties are not favorable since this compound has poor bioavailability, since it is rapidly and extensively metabolized and excreted. The therapeutic potential of resveratrol can only be adopted in vivo if the limitations related to its bioavailability can be overcome. Research programs are currently exploring other methods for enhancing resveratrol bioavailability, including: 1) co-administration with metabolism inhibitors in order to prolong its presence in vivo, 2) the use of resveratrol analogous endowed with a better bioavailability, and 3) a drug delivery system employing nanotechnology [50–52]. As far as concerns the first approach, some authors have evaluated the possibility of enhancing the pharmacokinetic parameters of resveratrol by partially inhibiting its glucuronidation by means of co-administration with specific inhibitors [53].
Interest is also increasing in the second strategy, which consists in evaluation of new naturally-occurring and/or synthetic analogous of resveratrol endowed with the same structural backbone and some chemical modifications resulting in better efficacy [54]. In this context, the biological activity exerted by resveratrol metabolites is still debated. Therefore, further studies are needed, including the possibility to induce deglycosylation to release resveratrol into the target tissues [55]. Conventional formulations alone are probably inadequate to bring solutions to the physicochemical and pharmacokinetic limitations governing resveratrol bioavailability. To overcome this problem, novel drug delivery systems have been proposed to protect and stabilize resveratrol and to enhance its bioavailability. Nano- and micro-formulations for resveratrol encapsulation that include liposomes, polymeric nanoparticles, solid lipid nanoparticles, lipospheres, cyclodextrins, polymeric microspheres, yeast cell carriers and calcium or zinc pectinate beads, have been developed for resveratrol delivery [56]. The mode of drug delivery systems able to enhance resveratrol bioavailability is particularly promising. Research is currently focused on exploring multiparticulate forms in the millimeter to micrometer range and colloidal carriers in the nanometer range. As far as concerns route of administration research has focused on oral forms as these offer the possibility, if necessary, of easy chronic administration, but parenteral forms which avoid intestinal metabolism are also envisaged for acute treatment. For all current formulation attempts, the main issue is to determine whether the drug delivery system is efficient in improving the pharmacokinetic profile of resveratrol and promoting the in vivo therapeutic effects. Perspectives now lie in the development of innovative formulations able to overcome all the limitations governing resveratrol bioavailability as a pre-requisite for efficient and to assure efficient and sustained delivery in vivo [56].
Resveratrol Production in Transgenic Plants
Metabolic engineering has provided a method to improve not only polyphenol composition but also its levels. Promising results have been obtained with STS-encoding genes in transgenic plants, thus confirming that plant molecular engineering with resveratrol may lead to a novel functional food for human consumption.
STS genes have been transferred to a number of crops, either to improve the resistance of plant to stresses or the nutritional value (see Tables 1 and 2). The presence of resveratrol enhanced plant resistance to biotic and abiotic stresses such as fungal pathogens and UV radiation. Two stilbene synthase genes from Vitis vinifera, (Vst1 and Stsy) have been the most common genes used for plant transformation (Table 1). Other STS-encoding genes have also been used, notably the AhRS gene from Arachis hypogea [57, 58], the SbSTS1 gene from Sorghum bicolor [59, 60] and an STS-encoding gene from Parthenocissus henryana [61]. Furthermore, to increase the levels of stilbene production, some investigators have used chimeric genes or a combination of two STS encoding genes (Vst1 and Vst2) [62–65].
Modulation of gene expression is primarily controlled by the promoter selected to drive the transgene. To date, the STS-encoding genes for plant transformation have been expressed under the control of a limited number of promoters, in particular the well-characterized constitutive promoter pCaMV35S, its own stress-responsive promoter pVst1, the fungus-inducible promoter pPR10.1 or the tissue-specific promoter p-nap [66, 67, 86]. As expected, the pCaMV35S promoter triggered strong and constitutive stilbene accumulation in most studies, but, as a consequence, in some cases, caused a drastic depletion of the endogenous pools of precursors [58].
Qualitative and quantitative comparisons between the different transgenic plants synthesizing resveratrol and related stilbenes are difficult, as different analytical methods are used to assay these compounds. These analyses have shown various stilbene levels and spatiotemporal distributions, leading to a considerable variability in terms of relative amounts of different forms.
In particular, the glycosylation of polyphenolic compounds occurs frequently in plants not only to protect cells from their potential toxic effects but also to prevent their oxidation and enzymatic degradation [59]. In the case of resveratrol, the free compound is first synthesized before being glycosylated by endogenous glycosyl-transferases. Free resveratrol and its glycosylated forms have both been detected in transgenic plants [59]. The stilbene content also depends strongly upon plant species, probably on account of different endogenous pools of enzymes or precursors, as well as differences in secondary metabolic pathways.
As far as concerns the amounts of stilbenes detected in the various studies, no common trend has been found, which may possibly be explained by the plant species as well as the specific genetic constructs used for transformation. In tomato and apple, the free to glycosylated resveratrol ratio naturally depends on the fruit ripening stage [64, 81]. These two compounds accumulate differentially in fruit tissues at the mature stage [83]. These variations may be the result of different endogenous β-glycosidase expression patterns. Even more than the plant species considered, the stilbene levels and forms in transgenic plants depend not only on the tissues or organs used as source material, but also on the fruit ripening stages [83].
In transgenic tomato, resveratrol synthesis was found to increase the overall antioxidant properties of the fruit, as well as the ascorbate/glutathione content [81] with a consequent two-fold increase in antioxidant activity of fruits. In another study, the hetherologous expression of STS in oilseed grape, combined with sinapate glucosyltransferase gene shutdown, considerably decreased the undesirable sinapate ester contents, thus improving the forage quality obtained from modified plants [86]. Taken together, these results suggest the overall relevance of STS-heterologous expression approach to obtain improved disease resistance and nutritional quality of agricultural crops and food products.
Functional Foods: Development and Investigations of the Effects of Resveratrol in Various Pathological Conditions
Metabolic engineering of plants will allow the development of foods with enhanced levels of various phytonutrients. It has been demonstrated for tomato plants where lines enhanced with flavonols have been developed by engineering the fruit-specific expression of a transcription factor that activates flavonol biosynthesis [88–90]. The improvement of resveratrol content in transgenic plants might benefit of this approach in the next future. Comparison of the effects of diets containing tomatoes enriched in different polyphenol classes upon onset and progression of diseases in cell assays or animal disease models will allow a quantitative assessment of the efficacy of different flavonoids within a common fruit matrix. One of the most intriguing results emerging from recent studies is that purified polyphenols, distributed as dietary supplements, do not have the same effects in promoting health as the same phytonutrients in a food context [91–93].
The nutritional context could influence the effects of polyphenols by affecting their bioavailability or be the result of various dietary phytonutrients acting synergistically, once absorbed [93, 94]. The impact of food on the efficacy of phytonutrients in promoting health could be assayed by comparing the effects of phytonutrients, to the same extent, in different foods in animal models [95–97]. Once functional food materials have been developed, the impact of target phytonutrients on a range of different chronic diseases can be assessed. For example, the pellets supplemented with resveratrol synthesizing tomato are currently being used in various disease models to assess the impact of transgenic tomato. In this way, studies on phytonutrients can evolve from models to humans using exactly the same experimental food matrix. The scientific information can then be used to program the development of new improved food products and the inclusion of these food products in dietary recommendations for specific disorders [97].
Conclusions
Metabolic engineering is generally defined as the redirection of one or more enzymatic reactions to improve the production of existing compounds, produce new compounds, or mediate the degradation of undesirable compounds. It involves the redirection of cellular activities by modifying the enzymes, endocellular localization, and regulatory functions within cells. Even more sophisticated metabolomic tools and analysis systems will offer the possibility to study both the primary and secondary metabolic pathways in an integrated fashion. Some interesting and important developments may be expected from plant transformation with STS gene. For example, promising results have been obtained with STS-encoding genes in transgenic plants, confirming that disease resistance can arise from foreign phytoalexin expression. In addition, plant molecular engineering with STS gene may lead to food products comprising edible legumes, cereals or fruits, which can be ingested, with their potential clinical benefits, by humans.
Taken together, these results suggest the general relevance of STS-encoding sequences as a tool for engineering disease resistance and the nutritional quality of agricultural crops and food products.
Therefore, further progress in a better understanding of the metabolic pathways and our ability to manipulate gene expression, in genetically modified plants, can be envisaged. The success of this approach depends upon the possibility to change the host metabolism and will depend primarily on a far more sophisticated knowledge of plant metabolism, especially the nuances of interconnected cellular networks.
Identifying rate-limiting steps in the synthesis of specific metabolites could provide targets for genetically engineering biochemical pathways to produce increased amounts of compounds as well as new compounds. Together with traditional plant breeding, genetic engineering provides great opportunities to develop plants with the desired levels and/or composition of specific polyphenols.
References
Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM (1995) The red wine phenolics trans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Clin Chim Acta 235:207–219
Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Metha RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218–220
Fremont L (2000) Biological effects of resveratrol. Life Sci 66:663–673
Shan C, Yang S, He H, Shao S, Zhang P (1990) Influences of 3, 4, 5′-trihydroxystilbene-3-β-mono-D-glucoside on rabbits platelet aggregation and thromboxane B2 production in vitro. Acta Pharmacol Sin 11:527–530
Gehm BD (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci USA 94:14138–14143
Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L, Maga G, Forti L, Pagnoni UM, Albini A, Prosperi E, Vannini V (2001) Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 276:22586–22594
Frankel EN, Waterhouse AL, Kinsella JE (1993) Inhibition of human LDL oxidation by resveratrol. Lancet 24:1103–1104
Kinsella JE, Frankel E, German B, Kanner J (1993) Possible mechanisms for the protective role of antioxidants in wine and plant foods. Food Technol 4:85–89
Burkardt PK, Beyer P, Wunn J, Kloti A, Armstrong GA, Schledz M, von Lintig J, Potrykus I (1997) Transgenic rice (Oryza sativa) endosperm expressing daffodil (Narcissus pseudonarcissus) phythoene synthase accumulates phytoene, a key intermediate of provitamin A biosynthesis. Plant J 11:1071–1078
DellaPenna D (2001) Plant metabolic engineering. Plant Physiol 125:160–163
Verhoeyen ME, Bovy A, Collins G, Muir S, Robinson S, de Vos CHR, Colliver S (2002) Increasing antioxidant levels in tomatoes through modification of the flavonoid biosynthetic pathway. J Exp Bot 53:2099–2106
Martin C, Butelli E, Petroni K, Tonelli C (2012) How can research on plants contribute to promoting human health? Plant Cell 23:1685–1699
Sparvoli F, Martin C, Scienza A, Gavazzi G, Tonelli C (1994) Cloning and molecular analysis of structural genes involved in flavonoid and stilbene biosynthesis in grape (Vitis vinifera L.). Plant Mol Biol 24:743–755
Bais AJ, Murphy PJ, Dry IB (2000) The molecular regulation of stilbene phytoalexin biosynthesis in Vitis vinifera during grape berry development. Aust J Plant Physiol 27:425–433
Donnez D, Jeandet P, Clément C, Courot E (2009) Bioproduction of resveratrol and stilbene derivatives by plant cells and microorganisms. Trends Biotechnol 27:706–713
Jandet P, Douillet-Breuil AC, Bessis R, Debord S, Sbaghi M, Adrian M (2002) Phytoalexins from the vitaceae: Biosynthesis, phytoalexin gene expression in transgenic plants, antifungal activity, and metabolism. J Agric Food Chem 50:2731–2741
Soleas GJ, Diamandis EP, Goldberg DM (2001) The world of resveratrol. Adv Exp Med Biol 492:159–182
Jeandet P, Bessis R, Maume BF, Meunier P, Peyron D, Trollat P (1995) Effect of enological practices on the resveratrol isomer content of wine. J Agric Food Chem 43:316–319
Stervbo U, Vang O, Bonnesen C (2007) A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine. Food Chem 101:449–457
Szajdek A, Borowska EJ (2008) Bioactive compounds and health-promoting properties of berry fruits: A review. Plant Foods Hum Nutr 63:147–156
Manach C, Scalbert A, Morand C, Rémésy C, Jimenez L (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79:727–747
Counet C, Callemien D, Collin S (2006) Chocolate and cocoa: New sources of trans-resveratrol and trans-piceid. Food Chem 98:649–657
Paredes-López O, Cervantes-Ceja ML, Vigna-Pérez M, Hernández-Pérez T (2010) Berries: Improving human health and healthy aging, and promoting quality life- A review. Plant Foods Hum Nutr 65:299–308
Castrejón ADR, Eichholz I, Rohn S, Kroh LW, Huyskens-Keil S (2008) Phenolic profile and antioxidant activity of high bush blueberry (Vaccinium corymbosum L.) during fruit maturation and ripening. Food Chem 109:564–572
Vitrac X, Moni JP, Vercauteren J, Deffieux G, Mérillon JM (2002) Direct liquid chromatography analysis of resveratrol derivatives and flavanonols in wines with absorbance and fluorescence detection. Anal Chim Acta 458:103–110
Deytieux C, Geny L, Lapaillerie D, Claverol S, Bonneu M, Donèche B (2007) Proteome analysis of grape skins during ripening. J Exp Bot 58:1851–1862
Iriti M, Faoro F (2009) Bioactivity of grape chemicals for human health. Nat Prod Commun 4:611–634
Jaillon O, Aury JM, Noel B, Policriti A, Clepet C, Casagrande A, Choisne N, Aubourg S, Vitulo N, Jubin C, Vezzi A, Legeai F, Hugueney P, Dasilva C, Horner D, Mica E, Jublot D, Poulain J, Bruyère C, Billault A, Segurens B, Gouyvenoux M, Ugarte E, Cattonaro F, Anthouard V, Vico V, Del Fabbro C, Alaux M, Di Gaspero G, Dumas V, Felice N, Paillard S, Juman I, Moroldo M, Scalabrin S, Canaguier A, Le Clainche I, Malacrida G, Durand E, Pesole G, Laucou V, Chatelet P, Merdinoglu D, Delledonne M, Pezzotti M, Lecharny A, Scarpelli C, Artiguenave F, Pè ME, Valle G, Morgante M, Caboche M, Adam-Blondon AF, Weissenbach J, Quétier F, Wincker P, French-Italian Public Consortium for Grapevine Genome Characterization (2007) The grapevine genome sequence suggests ancestral hexaploidization in major angiosperm phyla. Nature 449:463–467
Zamboni A, Di Carli M, Guzzo F, Stocchero M, Zenoni S, Ferrarini A, Tononi P, Toffali K, Desiderio A, Lilley KS, Pe EM, Benvenuto E, Delledonne M, Pezzotti M (2010) Identification of putative stage-specific grapevine berry biomarkers and omics data integration into networks. Plant Physiol 154:1439–1459
Frei B (2004) Efficacy of dietary antioxidants to prevent oxidative damage and inhibit chronic disease. J Nutr 134:3196–3198
Kundu JK, Surh YJ (2008) Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives. Cancer Lett 269:243–261
Kundu JK, Shin YK, Kim SH, Surh YJ (2006) Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity. Carcinogenesis 27:1465–1474
Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, Dannenberg AJ (1998) Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 273:21875–21882
Carluccio MA, Ancora MA, Massaro M, Carluccio M, Scoditti E, Distante A, Storelli C, De Caterina R (2007) Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation: Protective role of Mediterranean diet polyphenolic antioxidants. Am J Physiol Heart Circ Physiol 293:2344–2354
Csiszar A, Smith K, Labinsky N, Orosz Z, Rivera A, Ungvari Z (2006) Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: Role of NF-kappaB inhibition. Am J Physiol Heart Circ Physiol 291:1694–1699
Shankar S, Nall D, Tang SN, Meeker D, Passarini J, Sharma J, Srivastava RK (2011) Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition. PLoS One 6:e16530
Vergara D, Simeone P, Toraldo D, Del Boccio P, Vergaro V, Leporatti S, Pieragostino D, Tinelli A, De Domenico S, Alberti S, Urbani A, Salzet M, Santino A, Maffia M (2012) Resveratrol downregulates Akt/GSK and ERK signalling pathways in OVCAR-3 ovarian cancer cells. Mol Biosyst 8:1078–1087
Sharma S, Chopra K, Kulkarni SK (2007) Effect of insulin and its combination with resveratrol or curcumin in attenuation of diabetic neuropathic pain: Participation of nitric oxide F TNF-alpha. Phytother F Res 21:278–283
Anekonda TS (2006) Resveratrol a boon for treating Alzheimer’s disease? Brain Res Rev 52:316–326
Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430:686–689
Park SJ, Ahmad F, Philp A, Baar K, Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, Kim MK, Beaven MA, Burgin AB, Manganiello V, Chung JH (2012) Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 14:421–433
Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, de Cabo R (2008) Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 8:157–168
Lippi G, Franchini M, Favaloro EJ, Targher G (2010) Moderate red wine consumption and cardiovascular disease risk: Beyond the “French paradox”. Semin Thromb Hemost 36:59–70
Lippi G, Franchini M, Guidi GC (2010) Red wine and cardiovascular health: The “French paradox” revisited. Int J Wine Res 2:1–7
Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004) Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res 24:2783–2840
Fulda S (2010) Resveratrol and derivatives for the prevention and treatment of cancer. Drug Discov Today 15:757–765
Walle T, Hsieh F, DeLegge MH, Oatis JE Jr, Walle UK (2004) High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos 32:1377–1382
Walle T (2011) Bioavailability of resveratrol. Ann N Y Acad Sci Jan Sci 121:9–15
Wenzel E, Somoza V (2005) Metabolism and bioavailability of trans-resveratrol. Mol Nutr Food Res 49:472–481
Johnson JJ, Nihal M, Siddiqui IA, Scarlett CO, Bailey HH, Mukhtar H, Ahmad N (2011) Enhancing the bioavailability of resveratrol by combining it with piperine. Mol Nutr Food Res 55:1169–1176
Szekeres T, Saiko P, Fritzer-Szekeres M, Djavan B, Jäger W (2011) Chemopreventive effects of resveratrol and resveratrol derivatives. Ann N Y Acad Sci 1215:89–95
Goldberg DM, Yan J, Soleas GJ (2003) Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 36:79–87
Hoshino J, Park EJ, Kondratyuk TP, Marler L, Pezzuto JM, van Breemen RB, Mo S, Li Y, Cushman M (2010) Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. J Med Chem 53:5033–5043
Cai H, Sale S, Britton RG, Brown K, Steward WP, Gescher AJ (2011) Pharmacokinetics in mice and metabolism in murine and human liver fractions of the putative cancer chemopreventive agents 3,4,5,5,7-pentamethoxyflavone and tricin (4,5,7-trihydroxy-3,5-dimethoxyflavone). Cancer Chemother Pharmacol 67:255–263
Hassan-Khabbar S, Cottart CH, Wendum D, Vibert F, Clot JP, Savouret JF, Conti M, Nivet-Antoine V (2008) Post ischemic treatment by trans-resveratrol in rat liver ischemia–reperfusion: A possible strategy in liver surgery. Liver Transpl 14:451–459
Amri A, Chaumeil JC, Sfar S, Charrueau C (2012) Administration of resveratrol: What formulation solutions to bioavailability limitations? J Control Release 158:182–193
Hain R, Reif HJ, Krause E, Langebartels R, Kindl H, Vornam B, Wiese W, Schmelzer E, Schreier PH, Stocker RH, Stenzel K (1993) Disease resistance results from foreign phytoalexin expression in a novel plant. Nature 361:153–156
Fisher R, Budde I, Hain R (1997) Stilbene synthase gene expression causes changes in flower color and male sterility in tobacco. Plant J 11:489–498
Hipskind JD, Paiva NL (2000) Constitutive accumulation of a resveratrol-glucoside in transgenic alfalfa increases resistance to Phoma medicaginis. Mol Plant Microbe Interact 13:551–562
Liu Z, Zhuang C, Sheng S, Shao L, Zhao W, Zhao S (2011) Overexpression of a resveratrol synthase gene (PcRS) from Polygonum cuspidatum in transgenic Arabidopsis causes the accumulation of trans-piceid with antifungal activity. Plant Cell Rep 30:2027–2036
Yu CKY, Lam CNW, Springob K, Schmidt J, Chu IK, Lo C (2006) Constitutive accumulation of cis-piceid in transgenic Arabidopsis overexpressing a sorghum stilbene synthase gene. Plant Cell Physiol 47:1017–1021
Liu S, Hu Y, Wang X, Zhong J, Lin Z (2006) High content of resveratrol in lettuce transformed with a stilbene synthase gene of Parthenocissus henryana. J Agric Food Chem 54:8082–8085
Thomzik JE, Stenzel K, Stocker R, Schrejer PH, Hain R, Stahl DJ (1997) Synthesis of a grapevine phythoalexin in transgenic tomatoes (Lycopersicon esculentum Mill.) conditions resistance against Phytophthora infestans. Physiol Mol Plant Pathol 51:265–278
Rühmann S, Treutter D, Fritsche S, Briviba K, Szankowski I (2006) Piceid (resveratrol glucoside) synthesis in stilbene synthase transgenic apple fruit. J Agric Food Chem 54:4633–4640
Szankowski I, Briviba K, Fleschhut J, Schönherr J, Jacobsen HJ, Kiesecker H (2003) Transformation of apple (Malus domestica Borkh.) with the stilbene synthase gene from grapevine (Vitis vinifera L.) and a PGIP gene from kiwi (Actinidia deliciosa). Plant Cell Rep 22:141–149
Coutos-Thévenot P, Poissont B, Bonomelli A, Yean H, Breda C, Buffard D, Esnaut R, Hain R, Boulay M (2001) In vitro tolerance to Botrytis cinerea of grapevine 41B rootstock in transgenic plants expressing the stilbene synthase Vst1 gene under the control of a pathogen-inducible PR 10 promoter. J Exp Bot 52:901–910
Fan C, Pu N, Wang X, Wang Y, Fang L, Xu W, Zhang J (2008) Agrobacterium-mediated genetic transformation of grapevine (Vitis vinifera L.) with a novel stilbene synthase gene from Chinese wild Vitis pseudoreticulata. Plant Cell Tiss Organ Cult 92:197–206
Stark-Lorenzen P, Nelke B, Hänßler G, Mühlbach HP, Thomzik JE (1997) Transfer of a grapevine stilbene synthase gene to rice (Oryza sativa L.). Plant Cell Rep 16:668–673
Yu CKY, Springob K, Schmidt J, Nicholson RL, Chu IK, Yip WK, Lo C (2005) A stilbene synthase gene (SbSTS1) is involved in host and non host defense responses in sorghum. Plant Physiol 138:393–401
Fettig S, Hess D (1999) Expression of a chimeric stilbene synthase gene in transgenic wheat lines. Transgenic Res 8:179–189
Serazetdinova L, Oldach K, Lörz H (2005) Expression of transgenic stilbene synthase in wheat causes the accumulation of unknown stilbene derivatives with antifungal activity. J Plant Physiol 162:985–1002
Leckband G, Lörz H (1998) Transformation and expression of a stilbene synthase gene of Vitis vinifera L. in barley and wheat for increased fungal resistance. Theor Appl Genet 6:1004–1012
Giorcelli A, Sparvoli F, Mattivi F, Tava A, Balestrazzi A, Vrhovsek U, Bollini R, Confalonieri M (2004) Expression of the stilbene synthase (StSy) gene from grapevine in transgenic white poplar results in high accumulation of the antioxidant compounds resveratrol glucosides. Transgenic Res 13:203–214
Seppänen SK, Syrjälä L, von Weissenberg K, Teeri TH, Paajanen L, Pappinen A (2004) Antifungal activity of stilbenes in vitro bioassays and in transgenic Populus expressing a gene encoding pinosylvin synthase. Plant Cell Rep 22:584–593
Zhu YJ, Agbayani R, Jackson MC, Tang CS, Moore PH (2004) Expression of the grapevine stilbene synthase gene VST1 in papaya provides increased resistance against diseases caused by Phytophthora palmivora. Planta 12:807–812
Vishnevetsky J, White TL Jr, Palmateer AJ, Flaishman M, Cohen Y, Elad Y, Velcheva M, Hanania U, Sahar N, Dgani O, Perl A (2011) Improved tolerance toward fungal diseases in transgenic Cavendish banana (Musa spp. AAA group) cv. Grand Nain. Transgenic Res 20:61–72
Richter A, de Kathen A, de Lorenzo G, Briviba K, Hain R, Ramsay G, Jacobsen HJ, Kiesecker H (2006) Transgenic peas (Pisum sativum) expressing polygalacturonase inhibiting protein from raspberry (Rubus idaeus) and stilbene synthase from grape (Vitis vinifera). Plant Cell Rep 25:1166–1173
Kobayashi C, Ding CK, Nakamura Y, Nakajima I, Matsumoto R (2000) Kiwifruits (Actinidia deliciosa) transformed with a Vitis stilbene synthase gene produce piceid (resveratrol-glucoside). Plant Cell Rep 19:904–910
Lim JD, Yun SJ, Chung IM, Yu CY (2005) Resveratrol synthase transgene expression and accumulation of resveratrol glycoside in Rehmannia glutinosa. Mol Breed 16:219–233
Hanhineva K, Kokko H, Siljanen H, Rogachev I, Aharoni A, Kärenlampi SO (2009) Stilbene synthase gene transfer caused alterations in the phenylpropanoid metabolism of transgenic strawberry (Fragaria x ananassa). J Exp Bot 60:2093–2106
Giovinazzo G, D’Amico L, Paradiso A, Bollini R, Sparvoli F, De Gara L (2005) Antioxidant metabolite profiles in tomato fruit constitutively expressing the grapevine stilbene synthase gene. Plant Biotechnol J 3:57–69
Schijlen EGWM, de Vos CHR, Jonker H, van den Broeck H, Molthoff J, van Tunen AJ, Martens S, Bovy A (2006) Pathway engineering for healthy phytochemicals leading to the production of novel flavonoids in tomato fruit. Plant Biotechnol J 4:433–444
Nicoletti I, DeRossi A, Giovinazzo G, Corradini D (2007) Identification an quantification of stilbenes in fruits of transgenic tomato plants (Lycopersicon sculentum Mill.) by reversed phase HPLC with photodiode array and mass detection. J Agric Food Chem 55:3304–3311
D’Introno A, Paradiso A, Scoditti E, D’Amico L, De Paolis A, Carluccio MA, Nicoletti I, DeGara L, Santino A, Giovinazzo G (2009) Antioxidant and anti-inflammatory properties of tomato fruit synthesizing different amount of stilbenes. Plant Biotechnol J 7:422–429
Ingrosso I, Bonsegna S, De Domenico S, Laddomada B, Blando F, Santino A, Giovinazzo G (2011) Novel findings into parthenocarpy in tomato: A stilbene synthase approach to induce male sterility. Plant Physiol Biochem 49:1092–1099
Hüsken A, Baumert A, Milkowski C, Becker HC, Strack D, Möllers C (2005) Resveratrol glycoside (piceid) synthesis in seeds of transgenic oilseed rape (Brassica napus L.). Theor Appl Genet 111:1553–1562
Schwekendiek A, Spring O, Heyerick A, Pickel B, Pitsch NT, Peschke F, de Keukeleire D, Weber G (2007) Constitutive expression of a grapevine stilbene synthase gene in transgenic hop (Humulus lupulus L.) yields resveratrol and its derivatives in substantial quantities. J Agric Food Chem 55:7002–7009
Niggeweg R, Michael AJ, Martin C (2004) Engineering plants with increased levels of the antioxidant chlorogenic acid. Nat Biotechnol 22:746–754
Butelli E, Titta L, Giorgio M, Mock HP, Matros A, Peterek S, Schijlen EGWM, Hall RD, Bovy AG, Luo J, Martin C (2008) Enrichment of tomato fruit with health-promoting anthocyanins by expression of select transcription factors. Nat Biotechnol 26:1301–1308
Luo J, Butelli E, Hil L, Parr A, Niggeweg R, Bailey P, Weisshaar B, Martin C (2008) AtMYB12 regulates caffeoyl quinic acid and flavonol synthesis in tomato: Expression in fruit results in very high levels of both types of polyphenol. Plant J 56:316–326
Liu RH (2004) Potential synergy of phytochemicals in cancer prevention: Mechanism of action. J Nutr 134:3479S–3485S
de Kok TM, van Breda SG, Manson MM (2008) Mechanisms of combined action of different chemopreventive dietary compounds: A review. Eur J Nutr 47:51–59
Prior RL, Wu XL, Gu LW, Hager TJ, Hager A, Howard LR (2008) Whole berries versus berry anthocyanins: Interactions with dietary fat levels in the C57BL/6 J mouse model of obesity. J Agric Food Chem 56:647–653
Titta L, Trinei M, Stendardo M, Berniakovich I, Petroni K, Tonelli C, Riso P, Porrini M, Minucci S, Pelicci PG, Rapisarda P, Reforgiato Recupero G, Morelli G (2010) Blood orange juice inhibits fat accumulation in mice. Int J Obes (Lond) 34:578–588
Cencic A, Langerholc T (2010) Functional cell models of the gut and their applications in food microbiology—A review. Int J Food Microbiol 141:S4–S14
Murcia MA, Martínez-Tomé M (2001) Antioxidant activity of resveratrol compared with common food additives. J Food Protect 64:379–384
Martin C, Butelli E, Petroni K, Tonelli C (2011) How can research on plants contribute to promoting human health? Plant Cell 23:1685–1699
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giovinazzo, G., Ingrosso, I., Paradiso, A. et al. Resveratrol Biosynthesis: Plant Metabolic Engineering for Nutritional Improvement of Food. Plant Foods Hum Nutr 67, 191–199 (2012). https://doi.org/10.1007/s11130-012-0299-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11130-012-0299-8